William Bommer
Cardiovascular Disease · Sacramento, CANPI 1326029794
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $160,767 of the $194,060 with a category attached, or 82.8%. 12 manufacturers reported payments, led by Boehringer Ingelheim at 29.1% of the total. Reporting peaked in 2019 at $141,804 and has fallen 95.7% since, to $6,039 in 2023. Among cardiovascular disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $995.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$57K
- Lilly USA, LLC$47K
- E.r. Squibb & Sons, L.L.C.$41K
- Pfizer$26K
- Regeneron Healthcare Solutions, Inc.$19K
- Sanofi-aventis U.S. LLC$4K
- plus $687 from 6 others
What the payments were for
- Consulting fees$8,8255%
- Speaking & faculty fees$160,76783%
- Travel & lodging$19,83910%
- Food & beverage$4,4842%
- Education$1450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 50 | $56,520 |
| Lilly USA, LLC | 52 | $46,822 |
| E.r. Squibb & Sons, L.L.C. | 33 | $41,450 |
| Pfizer | 28 | $26,008 |
| Regeneron Healthcare Solutions, Inc. | 21 | $18,864 |
| Sanofi-aventis U.S. LLC | 2 | $3,709 |
| Biotronik Inc. | 3 | $258 |
| Novo Nordisk | 2 | $233 |
| Shockwave Medical, Inc | 1 | $140 |
| Novartis | 1 | $25 |
| AstraZeneca | 1 | $17 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$194,060 in reported general payments places this provider in the 95th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in Sacramento
- Jason RogersSacramento$4.4M
- Gagan SinghSacramento$1.2M
- Thomas SmithSacramento$942K
- Edris AmanSacramento$516K
- Garrett WongSacramento$504K
- Jeffrey SouthardSacramento$193K
- Andrea SoaresSacramento$159K
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Matthew BudoffTorrance$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.